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Background: Type 1 diabetes mellitus in pregnant women is associated with an increased risk of congenital
malformations, obstetric complications, neonatal morbidity, and mortality. Our aim was to evaluate which factors
from the first trimester of pregnancy have a significant impact on the pregnancy outcomes of women with type 1
diabetes.
Methods: We included 94 pregnant women with type 1 diabetes in this study. In these patients, we analyzed the
influence of several diabetes-related parameters on the pregnancy outcome. We compared the parameters
between two cohorts: those with successful pregnancies and those with adverse pregnancy outcomes, defined as
spontaneous abortion or congenital malformations. The influence of several factors on the pregnancy outcome was
assessed using multivariate and univariate logistic regressions.
Results: The prevalence of adverse pregnancy outcomes was 28.7%, and was associated with poorer glycemic
control (p <0.001), lower frequency of daily self-monitoring tests (p <0.001), smoking status (p <0.001), alcohol
consumption (p <0.001), increased prevalence of chronic complications of diabetes, and the presence of ketosis.
However, the adverse outcomes were not significantly associated with age, duration of diabetes, presence of
thyroid disease, or body mass index. Furthermore, planned pregnancy was found to be a significant protective
factor (odds ratio, 0.15; p <0.001).
Conclusion: These results indicate that by carefully planning the pregnancy, ensuring optimal glycemic control,
and eliminating habitual risk factors, the fetal risk in pregnancies among women with type 1 diabetes may decrease
to a value similar to that noted in women without diabetes.
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Type 1 diabetes mellitus (T1DM) in pregnant women is
associated with a significant increase in the risk of con-
genital malformations, obstetric complications, neonatal
morbidity, and mortality [1]. The frequency of major
congenital malformations among fetuses of mothers with
T1DM was estimated to be approximately 6–10%, which
represents a 2–5-fold increase compared to the abnor-
malities noted in mothers without diabetes [2]. These in-
creases in risk are primarily related to poor glycemic* Correspondence: timarrz@yahoo.com
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unless otherwise stated.control during the first trimester of pregnancy, during
which organogenesis takes place [3]; however, the likeli-
hood hypoglycemic events and ketoacidosis should also
not be overlooked in such cases [4].
Achieving optimal glycemic control without the occur-
rence of hypoglycemic events is one of the most import-
ant factors influencing pregnancy prognosis [5]. This is
challenging because pregnancy itself results in an in-
crease in the insulin resistance among women, even in
women with T1DM—some reports have cited an in-
crease in the daily insulin need of up to 40%. In addition,
the daily insulin need was reported to fluctuate during
the entire pregnancy period, primarily due to hormonal
changes; previous studies have indicated the occurrencetd. This is an Open Access article distributed under the terms of the Creative
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creases, during the pregnancy period [6]. Diet habits,
particularly changes in the diet during pregnancy, should
also be considered as factors that make good glycemic
control difficult to achieve.
In 1989, the St. Vincent Declaration set a five-year aim
to decrease the unfavorable outcomes in pregnant
women with T1DM to the levels noted among pregnant
women without diabetes [7]. However, although the fetal
complications currently noted among pregnant women
with T1DM have improved, the risk of severe and fatal
outcomes is still significantly higher in pregnancies of
women with T1DM [8].
Since until now there are no studies to analyze the
pregnancy outcomes of the Romanian women with
T1DM, in the present study, we aimed to analyze the
pregnancies outcomes in this population and to evaluate
which clinical and biological factors from the first tri-
mester of pregnancy are significantly influencing the
prognosis of these pregnancies.
Methods
Patients
We enrolled 94 pregnant women with T1DM between
2007 and 2012 in this observational study, using a
population-based consecutive-case enrollment principle,
at their first visit to either the Diabetes Clinic of the Emer-
gency Hospital from Timisoara or Obstetrics Gynecology
Clinic of the same hospital, if the visit was in the first tri-
mester of pregnancy. The study design, protocol and in-
formed consent form were reviewed and approved by the
Ethics Committee of the Emergency Hospital Timisoara,
Romania; all patients signed the informed consent form
prior any study procedure or activity.
To assess the impact of the factors on the pregnancy
outcomes, the patients were divided according to the
pregnancy outcome into two cohorts: patients with ad-
verse pregnancy outcomes (APO) (including those with
fetal loss, spontaneous abortions, and congenital malfor-
mations) and those with normal births. The diagnosis of
spontaneous abortion was established by the gynecologist
which followed the pregnancy and the diagnosis of con-
genital malformations by the neonatologist respectively by
the pathologist in case of major congenital malformations
which led to perinatal death. We evaluated the differences
in age, duration of diabetes, HbA1c level and body mass
index (BMI), smoking status, alcohol consumption, pres-
ence of thyroid disorders, chronic complications of dia-
betes (retinopathy, neuropathy, and nephropathy), and the
occurrence of ketosis in the first trimester of pregnancy or
preeclamspia between the two groups.
During the pregnancy, 14 patients (14.9%) were treated
with insulin pumps, whereas the other 80 patients received
a basal-bolus insulin regimen, involving two injections ofneutral protamine Hagedorn and three injections with
regular insulin. All patients received diet counseling from a
specialized dietician during the pregnancy. With regard
to self-monitoring of blood glucose values, although the
guidelines recommend the need for extensive glucose pro-
file examinations, the Romanian Health Insurance com-
pany only covers the cost of one glucose strip daily; the
patients need to bear the cost of any additional strips used.
Clinical, anthropometric, and laboratory data
Data regarding patient age, history of prior pregnancy loss,
and smoking status were collected from the patients’ med-
ical records. The duration of diabetes was defined as the
time from the date of the first insulin injection until the
diagnosis of the pregnancy (confirmed by gynecological
examination). The HbA1c level was measured using a
NGSP-standardized and DCCT-compliant immune-
turbidimetric assay (Roche), having an inter-measurement
coefficient of variation of 1.64% according to manufac-
turer’s specifications. The screening for ketosis was per-
formed using Siemens Multistix 10 SG urine dipsticks. In
case of a positive dipstick test for urine ketones total serum
levels of ketone bodies were measured, a value higher than
1 mmol/L being considered a positive diagnosis for ketosis.
Urine ketones measurement was performed as a screening
method at every visit and also every patient was provided
with dipsticks for home measurement. In case of a positive
test for urine ketosis at home, patients were instructed to
contact their diabetologist and to come to hospital for
serum ketones measurement and treatment readjustment.
Screening for thyroid diseases was performed in all the pa-
tients by measuring the TSH and FT4 levels, and via a thy-
roid ultrasonography examination. Diabetic retinopathy
was diagnosed based on the results of ophthalmological
examination and eye fundus examination. The Michigan
Neuropathy Screening Instrument (MNSI) was used to
diagnose diabetic neuropathy; an MNSI score of >2.5 was
representative of a positive diagnosis [9]. Moreover, for the
diagnosis of diabetic nephropathy, spot urine albumin/cre-
atinine ratio tests were performed, and 3 mg/mmol was
considered as the threshold for clinically significant albu-
minuria. Alcohol consumption was assessed by using a
questionnaire adapted from the AUDIT-C screening tool
proposed by the ACQUIP study group; a score of ≥8 was
considered as the threshold for alcohol abuse [10]. Planned
pregnancy was defined in cases where the women clearly
intended to become pregnant, made extensive lifestyle
preparations, and made at least one visit to a gynecologist
and diabetologist prior to conception.
Statistical analysis
Data were collected and analyzed using the SPSS v.17
software suite (SPSS Inc. Chicago, IL, USA). Data are
presented as mean ± standard deviations for continuous
Table 2 Comparison between groups: pregnancies with





Number of cases 67 (71.3%) 27 (28.7%) -
Age* 26 [5] 25 [9] 0.212
Diabetes duration* 8 [11] 9 [7] 0.259
st
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tile range) for continuous variables without Gaussian
distribution, or percentages for categorical variables. The
lower and upper limits of the 95% confidence intervals
(CI), used to estimate the prevalence, were calculated ac-
cording to Wilson’s procedure for variables with Poisson
distribution. Moreover, the 95% CI for odds ratio (OR)
was calculated according to the mid-p method for bino-
mial distributions [11].
To assess the significance of the differences between
groups, the Student t-test (means, Gaussian popula-
tions), Mann-Whitney test (medians, non-Gaussian pop-
ulations), and Fisher’s exact test (proportions) were used.
Continuous variable distributions were tested for nor-
mality using D’Agostino’s and Pearson’s test, and for
equality of variances using Levene’s test. For evaluating
the involvement of one or more confounding factors in
dichotomous outcomes, univariate and multivariate lo-
gistic regression models were established; the goodness
of fit was estimated using Nagelkerke’s R2 method.
A p value of <0.05 was considered as the threshold for
statistical significance.
Results
The patients’ baseline characteristics are presented in
Table 1.
In total, 27 cases of APO were observed, leading to a
prevalence of 28.7%; of these cases, 21 (77.8%) were
caused by spontaneous abortions and 6 (22.2%) were
caused by congenital malformations: 4 cardiovascularTable 1 Patient’s baseline characteristics
Age* 26 [6]
Diabetes duration* 8 [10]
HbA1c (%) in the 1st trimester of pregnancy† 7.8 ± 1.4
BMI (kg/m2) in the 1st trimester of pregnancy† 23.5 ± 3.4
Daily insulin dose (U/kg)† 0.85 ± 0.25
Daily self-monitoring blood glucose tests† 2 [2]
Insulin-pump treatment‡ 14.9% (14)
Smokers‡ 44.7% (42)
Alcohol abuse‡ 8.5% (8)
Thyroid disease‡ 11.7% (11)
Diabetic retinopathy‡ 23.4% (22)
Diabetic neuropathy‡ 11.7% (11)
Diabetic nephropathy‡ 4.3% (4)
Planned pregnancy‡ 64.9% (61)
Ketosis in the 1st trimester of pregnancy‡ 21.3% (20)
Preeclampsia events (%) 16.0% (15)
*Distributions are not Gaussian. Data is presented as median and
[interquartile range].
†Data are presented as mean ± standard deviation.
‡Data are presented as percentages.malformations, one hydrocephaly and one esophageal
atresia. No maternal deaths or major maternal complica-
tions were recorded. APO was significantly associated with
poor glycemic control in the first trimester of pregnancy
(average HbA1c higher by 1.69 percentage points;
p <0.001), fewer daily blood glucose self-monitoring
tests (median, 1 vs. 3 tests; p <0.001), smoking status
(p <0.001), alcohol consumption (p <0.001), increased
prevalence of chronic complications of diabetes (retin-
opathy, p = 0.016; neuropathy, p = 0.012; nephropathy,
p = 0.037), and the presence of ketosis during the first
trimester of pregnancy (p <0.001). However, APO was
not significantly associated with age, duration of dia-
betes, BMI, preeclampsia events, and the presence of
thyroid disorders (Table 2). Planned pregnancy was
found to be a significant protective factor against the
risk of APO (OR = 0.15; 95% CI, 0.05– 0.38; p <0.001).
In the study group, no severe hypoglycemic events were
recorded.HbA1c (%) in the 1 trimester
of pregnancy†
7.33 ± 0.92 9.02 ± 1.6 <0.001
BMI (kg/m2) in the 1st trimester
of pregnancy†
23.32 ± 2.88 23.82 ± 4.35 0.586
Daily self-monitoring blood
glucose tests*
3 [3] 1 [2] <0.001
Smokers‡ 32.8% (22) 74.1% (20) <0.001
Alcohol abuse‡ 0% (0) 29.6% (8) <0.001
Thyroid disease‡ 13.4% (9) 7.4% (2) 0.503
Diabetic retinopathy‡ 16.4% (11) 40.7% (11) 0.016
Diabetic neuropathy‡ 6.0% (4) 25.9% (7) 0.012
Diabetic nephropathy‡ 1.5% (1) 7.4% (2) 0.037
Planned pregnancy‡ 79.1% (53) 29.6% (8) <0.001
Ketosis in the 1st trimester of
pregnancy‡
10.4% (7) 48.1% (13) <0.001
Preeclampsia events‡ 14.9% (10) 18.5% (5) 0.757
*Distributions are not Gaussian. Data is presented as median and [interquartile
range]; p was calculated with Mann-Whitney U test.
†Data is presented as mean ± standard deviation; p was calculated with
t-student test.
‡Data is presented as percentages; p was calculated with chi-square test.
Continuous variables distributions were tested for normality using
Shapiro-Wilk test and for equality of variances with Levene’s test.
APO – Adverse pregnancy outcome.
HbA1c - Hemoglobin A1c.
BMI – Body Mass Index.
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lyzed the impact of glycemic control during the first tri-
mester of pregnancy–using the HbA1c value–on the
prognosis of pregnancy. We noted an increase in the risk
of APO (OR = 3.07; 95% CI, 1.83–5.15; p <0.001) for
every 1 percentage point increase in the HbA1c value.
The multivariate logistic regression model indicated
that increases in the HbA1c level during the first trimes-
ter of pregnancy (OR = 2.78; p = 0.03) and planning of
the pregnancy (OR = 0.19; p = 0.02) were significant fac-
tors that independently influenced APO (Table 3,
Figure 1).
Discussion
To our knowledge, the present study is the first to
analyze the influence of different potential risk factors
for severe or fatal pregnancy outcomes in Romanian
women with T1DM. Although a series of related risk
factors that have already been reported in the literature
may be applicable to the Romanian population, the risk
factors may be different in Romanian women with
T1DM due to social and economic characteristics
among this group since the World Health Organization
reports a prevalence of congenital malformations in gen-
eral population of Romania as being 22 per 1,000 preg-
nancies, compared to an average of 3.19 per 1,000 in the
European Region [12]. Another strength of our study is
that we enrolled all the pregnancies of women with
T1DM from our region, during a six year timeframe.
The most important limit we identified is that the results
are reflecting only the situation from the West part of
Romania, being possible that some differences exists in
other regions.
In the present study, involving a representative group
of pregnant Romanian women with T1DM, we noted
that the findings regarding pregnancy prognosis were
similar to those obtained in other countries such as Eng-
land, Northern Ireland, or Wales [13], but were worse
compared to those found in Denmark, Italy or the
Netherlands [14-16]. An important observation is that
the value representing APO, among these studies, wasTable 3 Predictors for APO in women with T1DM
(multivariate logistic regression model; Nagelkerke
R2 = 0.565)
Predictor OR 95% CI p
HbA1c (per percentage point)* 2.78 1.4 to 5.45 0.03
Age (per one year) 1.13 0.97 to 1.31 0.11
BMI (per kg/m2) 1.01 0.84 to 1.22 0.91
Diabetes duration (per one year) 1.03 0.91 to 1.16 0.64
Smoking status (dichotomous) 2.74 0.74 to 10.17 0.13
Planned pregnancy (dichotomous)* 0.19 0.048 to 0.75 0.018
*Predictor is significant both independently and as a co-factor.strongly correlated with the presence or absence of the
factors already identified in the present study as signifi-
cant factors for pregnancy outcome. Also, when we
compared our results with results found in similar stud-
ies [13-16], excepting ones from the England, Northern
Ireland and Wales, we observed the existence of a strong
correlation between the prevalence of APO in pregnan-
cies of women with T1DM on one hand and the preva-
lence of APO in general population on the other hand,
the prevalence of APO in pregnancies of women with
T1DM being almost proportional with the prevalence of
APO in general population of these countries [12].
The early planning of pregnancy is one such factor,
which is one of the most important factors in the
present study and is also mentioned in other studies
[17,18]. Pregnancy planning is an important component
not only in women with T1DM, but also in the general
population; however, its role is augmented, due to a
series of specific characteristics in the former group [19].
In this group of women with T1DM, to decrease both
the maternal and fetal risks, a multidisciplinary approach
(particularly involving gynecology and diabetology spe-
cialists) is required, along with the consideration of cer-
tain factors, of which the important ones include
achieving an optimal glycemic control before pregnancy,
psychological support, and awareness of the features of
the metabolic state during pregnancy; we are already
aware that achieving glycemic control in pregnant
women is more challenging due to the hormonal and
dietary habit changes during this period [19,20]. All
these changes lead to a variable increase in the insulin
need during the pregnancy, thus requiring stricter self-
monitoring of blood glucose and concomitant adjust-
ments of insulin doses [6,21]. With regard to pregnancy
planning, an important measure adopted–not only
among those with T1DM–is the cessation of alcohol
consumption and smoking prior to the pregnancy. In
the present study, both smoking status and alcohol con-
sumption were associated with an augmented fetal risk.
Furthermore, through multivariate logistic regression
analysis, lack of pregnancy planning was found to be a
cofactor for fetal risk, along with the abovementioned
factors, indicating that timely planning has an indirect
role (the results being derived from planning interven-
tions) and is also a significant independent factor pro-
tecting against fetal risk.
The importance of the factors identified is underlined
by their independent nature of influence. In the present
study, achieving good glycemic control was found to be
a protective factor against adverse pregnancy outcomes;
however this decrease in the risk is probably strongly re-
lated to an improved glycemic control obtained in the
patients which self-monitored their blood glucose in a
more appropriate way. We noted that increased levels of
Figure 1 Multivariate risk analysis for APO; predictors from the first trimester of pregnancy. HbA1c – Hemoglobin A1c (risk is expressed
per one percentage point increase); Age (risk is expressed per one year increase); BMI – Body Mass Index (risk is expressed per one kg/m2
increase); Diabetes duration (risk is expressed per one year increase); Smoker (risk is expressed as dichotomous variable); Planned pregnancy
(risk is expressed as dichotomous variable).
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which organogenesis occurs, are associated with signifi-
cant increases in the fetal risk. Considering that the insulin
need fluctuates during this period, the glucose levels re-
quire frequent measuring for adjusting the insulin doses.
Thus, adequate self-monitoring during the entire preg-
nancy period is essential to achieve good glycemic control.
The impact of habitual risk factors such as smoking
status and alcohol consumption has been already identi-
fied for pregnancies that are not complicated by diabetes
[22,23]; the present results suggest that these factors
have a greater influence in pregnant cases with T1DM.
The increased proportion of smokers and women who
consumed alcohol during the pregnancy may contribute
to the higher prevalence of negative outcomes, as com-
pared to other studies wherein the fetal loss rate, along
with the incidence of these two factors, was lower. Thus,
the cessation of alcohol consumption and smoking at a
considerable duration prior to pregnancy appears to be
mandatory in women with T1DM. In our study the BMI
proved to have no significant impact on the pregnancy
outcome, the results being in contrast with ones found
by Persson et al. which described a worsening of the
pregnancy prognosis in women which had an increased
BMI prior pregnancy in a cohort of women with T1DM
[24]. Probably, our results revealed no significant impact
because the proportion of obese and overweight patients
was significantly smaller compared to Persson’s study,
thus in our study the occurrence of a type 2 statistical
error being possible, our cohort containing only 4 obese
patients prior pregnancy.
Another significant risk factor in the present study is
the presence of chronic (retinopathy, nephropathy, and
neuropathy) and acute (ketosis) complications of diabetes.In the group of patients with negative outcomes, we ob-
served significant increases in the proportion of patients
with complications. However, after excluding these factors
from our logistic regression model, we noted that the dur-
ation of diabetes and the mother’s age did not have a sig-
nificant impact on the pregnancy outcome. Nevertheless,
the duration of diabetes is known to be correlated with
the occurrence of complications, and may thus be indir-
ectly related to pregnancy prognosis [25].
Conclusions
Based on the current findings, the presence of T1DM
may be considered as only a fetal and not a maternal risk
factor. In addition, we did not observe any major mater-
nal complications or deaths in our cohort.
After analyzing the results of the present study and
evaluating them in the context of other published find-
ings, we conclude that by achieving good glycemic con-
trol and thus avoiding the occurrence of hypoglycemic
or ketosis events, as well as by eliminating the habitual
risk factors, the aim of the St. Vincent declaration of
1989 may be realized. Moreover, the results suggest that,
by implementing these measures, the fetal risk in women
with T1DM can be decreased to a value that is similar to
that in women without diabetes.
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